Corrigendum to “Effects of High-mobility Group Box1 on Cerebral Angiogenesis and Neurogenesis After Intracerebral Hemorrhage” [Neuroscience 229 (2013) 12–19](S0306452212010780)(10.1016/j.neuroscience.2012.10.054);Effects of high-mobility group box1 on cerebral angiogenesis and neurogenesis after intracerebral hemorrhage

Neuroscience

Volumn 229, Issue , 2013, Pages 12-19

  Lei, C ^a   Lin, S ^a   Zhang, C ^a   Tao, W ^a   Dong, W ^a   Hao, Z ^a   Liu, M ^a   Wu, B ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Angiogenesis; High mobility group box1; Intracerebral hemorrhage; Neurogenesis

Indexed keywords

BROXURIDINE; DOUBLECORTIN; HIGH MOBILITY GROUP BOX1 PROTEIN; HIGH MOBILITY GROUP PROTEIN; NERVE GROWTH FACTOR; PYRUVIC ACID DERIVATIVE; PYRUVIC ACID ETHYL ESTER; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN HEMATOMA; BRAIN HEMORRHAGE; CEREBRAL ANGIOGENESIS; CONTROLLED STUDY; CORPUS STRIATUM; NERVE REGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT;

EID: 84870369479     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2021.12.001     Document Type: Erratum

References (40)

1. Andersson U., Erlandsson-Harris H., Yang H., Tracey K.J. HMGB1 as a DNA-binding cytokine. J Leukoc Biol 2002, 72:1084-1091.
2. Barkho B.Z., Munoz A.E., Li X., Li L., Cunningham L.A., Zhao X. Endogenous matrix metalloproteinase (MMP)-3 and MMP-9 promote the differentiation and migration of adult neural progenitor cells in response to chemokines. Stem Cells 2008, 26:3139-3149.
3. Biscetti F., Straface G., De Cristofaro R., Lancellotti S., Rizzo P., Arena V., Stigliano E., Pecorini G., Egashira K., De Angelis G., Ghirlanda G., Flex A. High-mobility group box-1 protein promotes angiogenesis after peripheral ischemia in diabetic mice through a VEGF-dependent mechanism. Diabetes 2010, 59:1496-1505.
4. Chavakis E., Hain A., Vinci M., Carmona G., Bianchi M.E., Vajkoczy P., Zeiher A.M., Chavakis T., Dimmeler S. High-mobility group box 1 activates integrin-dependent homing of endothelial progenitor cells. Circ Res 2007, 100:204-212.
5. Chen J., Li Y., Wang L., Zhang Z., Lu D., Lu M., Chopp M. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 2001, 32:1005-1011.
6. Chopp M., Zhang Z.G., Jiang Q. Neurogenesis, angiogenesis, MRI indices functional recovery from stroke. Stroke 2007, 38:827-831.
7. Cristofaro B., Emanueli C. Possible novel targets for therapeutic angiogenesis. Curr Opin Pharmacol 2009, 9:102-108.
8. del Zoppo G.J. The neurovascular unit, matrix proteases, and innate inflammation. Ann N Y Acad Sci 2010, 1207:46-49.
9. Font M.A., Arboix A., Krupinski J. Angiogenesis, neurogenesis and neuroplasticity in ischemic stroke. Curr Cardiol Rev 2010, 6:238-244.
10. Hayakawa K., Mishima K., Nozako M., Hazekawa M., Mishima S., Fujioka M., Orito K., Egashira N., Iwasaki K., Fujiwara M. Delayed treatment with minocycline ameliorates neurologic impairment through activated microglia expressing a high-mobility group box1-inhibiting mechanism. Stroke 2008, 39:951-958.
11. Hayakawa K., Qiu J., Lo E.H. Biphasic actions of HMGB1 signaling in inflammation and recovery after stroke. Ann N Y Acad Sci 2010, 1207:50-57.
12. Hayakawa K., Nakano T., Irie K., Higuchi S., Fujioka M., Orito K., Iwasaki K., Jin G., Lo E.H., Mishima K., Fujiwara M. Inhibition of reactive astrocytes with fluorocitrate retards neurovascular remodeling and recovery after focal cerebral ischemia in mice. J Cereb Blood Flow Metab 2010, 30:871-882.
13. Huttunen H.J., Kuja-Panula J., Sorci G., Agneletti A.L., Donato R., Rauvala H. Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation. J Biol Chem 2000, 275:40096-40105.
14. Huttunen HJ., Kuja-Panula J., Rauvala H. Receptor for advanced glycation end products (RAGE) signaling induces CREB-dependent chromogranin expression during neuronal differentiation. J Biol Chem 2002, 277:38635-38646.
15. Hwang B.Y., Appelboom G., Ayer A., Kellner C.P., Kotchetkov I.S., Gigante P.R., Haque R., Kellner M., Connolly E.S. Advances in neuroprotective strategies: potential therapies for intracerebral hemorrhage. Cerebrovasc Dis 2011, 31:211-222.
16. Kao K.K., Fink M.P. The biochemical basis for the anti-inflammatory and cytoprotective actions of ethyl pyruvate and related compounds. Biochem Pharmacol 2010, 80:151-159.
17. Kim J.B., Sig Choi J., Yu Y.M., Nam K., Piao C.S., Kim S.W., Lee M.H., Han P.L., Park J.S., Lee J.K. HMGB1, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain. J Neurosci 2006, 26:6413-6421.
18. Kreutzberg G.W. Microglia: a sensor for pathological events in the CNS. Trends Neurosci 1996, 19:312-318.
19. Krum J.M., Mani N., Rosenstein J.M. Roles of the endogenous VEGF receptors flt-1 and flk-1 in astroglial and vascular remodeling after brain injury. Exp Neurol 2008, 212:108-117.
20. Limana F., Germani A., Zacheo A., Kajstura J., Di Carlo A., Borsellino G., Leoni O., Palumbo R., Battistini L., Rastaldo R., Müller S., Pompilio G., Anversa P., Bianchi M.E., Capogrossi M.C. Exogenous high mobility group box 1 protein induces myocardial regeneration after infarction via enhanced cardiac C-kit+ cell proliferation and differentiation. Circ Res 2005, 97:e73-e83.
21. Luan Z.G., Zhang H., Yang P.T., Ma X.C., Zhang C., Guo R.X. HMGB1 activates nuclear factor-kB signaling by RAGE and increases the production of TNF-a in human umbilical vein endothelial cells. Immunobiology 2010, 215:956-962.
22. Naglova H., Bucova M. HMGB1 and its physiological and pathological roles. Bratisl Lek Listy 2012, 113:163-171.
23. Navaratna D., Guo S., Arai K., Lo E.H. Mechanisms and targets for angiogenic therapy after stroke. Cell Adh Migr 2009, 3:216-223.
24. Ohnishi M., Katsuki H., Fukutomi C., Takahashi M., Motomura M., Fukunaga M., Matsuoka Y., Isohama Y., Izumi Y., Kume T., Inoue A., Akaike A. HMGB1 inhibitor glycyrrhizin attenuates intracerebral hemorrhage-induced injury in rats. Neuropharmacology 2011, 61:975-980.
25. Qi J., Zheng Y., Wei Y., Zhu X., Lo E.H., Moskowitz M.A., Sims J.R. High-mobility group box1 promotes metalloproteinase-9 upregulation through toll-like receptor 4 after cerebral ischemia. Stroke 2010, 41:2077-2082.
26. Qiu J., Nishimura M., Wang Y., Sims J.R., Qiu S., Savitz S.I., Salomone S., Moskowitz M.A. Early release of HMGB1 from neurons after the onset of brain ischemia. J Cereb Blood Flow Metab 2008, 28:927-938.
27. Rossini A., Zacheo A., Mocini D., Totta P., Facchiano A., Castoldi R., Sordini P., Pompilio G., Abeni D., Capogrossi M.C., Germani A. HMGB1-stimulated human primary cardiac fibroblasts exert a paracrine action on human and murine cardiac stem cells. J Mol Cell Cardiol 2008, 44:683-693.
28. Sansing L.H., Harris T.H., Welsh F.A., Kasner S.E., Hunter C.A., Kariko K. Receptor 4 contributes to poor outcome after intracerebral hemorrhage. Ann Neurol 2011, 70:646-656.
29. Schlueter C., Weber H., Meyer B., Rogalla P., Roser K., Hauke S., Bullerdiek J. Angiogenetic signaling through hypoxia: HMGB1: an angiogenetic switch molecule. Am J Pathol 2005, 166:1259-1263.
30. Shang J., Deguchi K., Ohta Y., Liu N., Zhang X., Tian F., Yamashita T., Ikeda Y., Matsuura T., Funakoshi H., Nakamura T., Abe K. Strong neurogenesis, angiogenesis, synaptogenesis, and antifibrosis of hepatocyte growth factor in rats brain after transient middle cerebral artery occlusion. J Neurosci Res 2011, 89:86-95.
31. Shimotake J., Derugin N., Wendland M., Vexler Z.S., Ferriero D.M. Vascular endothelial growth factor receptor-2 inhibition promotes cell death and limits endothelial cell proliferation in a neonatal rodent model of stroke. Stroke 2010, 41:343-349.
32. Su X., Wang H., Zhao J., Pan H., Mao L. Beneficial effects of ethyl pyruvate through inhibiting high-mobility group box 1 expression and TLR4/NF-kB pathway after traumatic brain injury in the rat. Mediators Inflamm 2011, 2011:807142.
33. Tang T., Liu X.J., Zhang Z.Q., Zhou H.J., Luo J.K., Huang J.F., Yang Q.D., Li X.Q. Cerebral angiogenesis after collagenase-induced intracerebral hemorrhage in rats. Brain Res 2007, 1175:134-142.
34. Tang D., Kang R., Livesey K.M., Cheh C.W., Farkas A., Loughran P., Hoppe G., Bianchi M.E., Tracey K.J., Zeh H.J., Lotze M.T. HMGB1 regulates autophagy. J Cell Biol 2010, 190:881-892.
35. Xiong Y., Mahmood A., Chopp M. Angiogenesis, neurogenesis and brain recovery of function following injury. Curr Opin Investig Drugs 2010, 11:298-308.
36. Yang H., Ochani M., Li J., Qiang X., Tanovic M.E., Harris H., DiRaimo R., Czura C.J., Wang H., Roth J., Warren H.S., Fink M.P., Fenton M.J., Andersson U., Tracey K.J. Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc Natl Acad Sci U S A 2004, 101:296-301.
37. Yang S., Song S., Hua Y., Nakamura T., Keep R.F., Xi G. Effects of thrombin on neurogenesis after intracerebral hemorrhage. Stroke 2008, 39:2079-2084.
38. Yu Y.M., Kim J.B., Lee K.W., Kim S.Y., Han P.L., Lee J.K. Inhibition of the cerebral ischemic injury by ethyl pyruvate with a wide therapeutic window. Stroke 2005, 36:2238-2243.
39. Zhang J., Zhu J.S., Zhou Z., Chen W.X., Chen N.W. Inhibitory effects of ethyl pyruvate administration on human gastric cancer growth via regulation of the HMGB1-RAGE and Akt pathways in vitro and in vivo. Oncol Rep 2012, 27:1511-1519.
40. Zhao B.Q., Tejima E., Lo E.H. Neurovascular proteases in brain injury. Hemorrhage and remodeling after stroke. Stroke 2007, 38:748-752.